# Atossa Therapeutics, Inc.: Form 8-K, filed Oct 14, 2025

- Company: [Atossa Therapeutics, Inc.](/companies/atos.md) (CIK 1488039)
- Form: 8-K
- Filed: 2025-10-14
- Accepted by EDGAR: Oct 14, 2025, 07:50 ET
- Period: 2025-10-14
- Accession: 0001193125-25-238065
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1488039/000119312525238065/atos-20251014.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1488039/000119312525238065/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1488039/000119312525238065/atos-20251014.htm

Filed Oct 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-238065. Last ingested by Listed: Nov 10, 2026, 17:09 ET. No prices; not investment advice.